Inside Precision Medicine March 1, 2024
The Advanced Research Projects Agency for Health (ARPA-H) is allocating up to $48 million to the non-profit Every Cure in Philadelphia for repurposing approved drugs for rare diseases. The award includes the potential for additional funds to validate the most promising drug-disease matches in clinical trials.
“This project will harness AI to find answers and treatments for the 30 million Americans who are currently facing rare diseases,” said Arati Prabhakar, PhD, director of the White House Office of Science of Technology Policy.
The ML/AI-Aided Therapeutic Repurposing In eXtended uses (MATRIX) project intends to build a machine learning platform to rapidly pinpoint and validate existing medications to treat diseases that currently have no therapies. For the more than 10,000 known rare...
Today's Sponsors
Today's Sponsor